Compositions and methods for the detection and analysis of mycobacterium tuberculosis

• US 10,072,306 B2
• Filed: 07/07/2015
• Issued: 09/11/2018
• Est. Priority Date: 07/24/2014
• Status: Active Grant

• Current Assignee: Abbott Molecular Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Molecular Incorporated (Abbott Laboratories)
• Inventors: Tang, Ning, Leckie, Gregor, Pahalawatta, Vihanga, Frank, Andrea, Lampinen, John
• Primary Examiner(s): Wilder, Cynthia B
• Application Number:
  US14/793,241
• Publication Number:
  US 20160024561A1
• Time in Patent Office: 1,162 Days
• Field of Search: 435 912
• CPC Class Codes: C12Q 1/689 for bacteria

Abstract

Provided herein are compositions and methods useful for the detection of MTB. In particular, provided herein are kits, reagents, reaction mixtures, and methods involving such for nucleic acid amplification and detection procedures, which specifically and sensitively detect MTB in samples.

Claims

1. A method of identifying Mycobacterium tuberculosis (MTB) nucleic acid in a biological sample, comprising:

a) contacting a biological sample from a subject with at least two nucleic acid primer pairs selected from the group consisting of SEQ ID NOS;

1-4, 7 and 8 and at least two probes selected from the group consisting of SEQ ID NOS;

5, 6 and 9, and

b) detecting the binding of said nucleic acid primer or probe to said MTB nucleic acid.

2. The method of claim 1, wherein said detecting comprises real time PCR.

3. The method of claim 1, wherein said method further comprises the step of inactivating said MTB in said sample using an inactivation reagent prior to said contacting.

4. The method of claim 3, wherein said inactivation reagent comprises water, a detergent, an alcohol, and NaOH.

5. The method of claim 3, wherein said inactivation reagent comprise isopropanol, sodium hydroxide, polyoxyethylene (2) sorbitan monolaurate, and water.

6. The method of claim 1, wherein said sample is sputum, bronchoalveolar lavage [BAL], or N-acetyl-L-cysteine [NALC] sediments of sputum.

7. The method of claim 1, wherein one or more of said SEQ ID NOS comprises a label.

8. The method claim 7, wherein said label comprises a fluorophore.

9. The method of claim 8, wherein said label comprises a fluorophore/quencher pair.

10. The method of claim 1, further comprising contacting said biological sample from said subject with one or more nucleic acid sequences selected from the group consisting of SEQ ID NOS:

10-36.

11. The method of claim 1, further comprising contacting said biological sample from said subject with a reaction mixture.

12. The method of claim 11, wherein said reaction mixture comprises a reagent selected from a nucleic acid polymerase, a plurality of dNTPs, a buffer and an inactivation agent.

13. The method of claim 1, further comprising contacting said biological sample from said subject with guanidinium thiocyanate and a magnetic microparticle.